Life-threatening reaction to staphylococcal protein A immunomodulation.
Smith
R E
RE
Department of Medicine, Medical College of Wisconsin, Milwaukee.
Gottschall
J L
JL
Pisciotta
A V
AV
D000328:Adult; D001327:Autoimmune Diseases / Q000628:therapy*; D002846:Chromatography, Affinity; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007163:Immunosorbent Techniques / Q000009:adverse effects*; D015994:Incidence; D011241:Prednisone / Q000627:therapeutic use; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000628:therapy*; D012713:Serum Sickness; D013205:Staphylococcal Protein A / Q000009:adverse effects*; D014581:Urticaria / Q000139:chemically induced*; D014657:Vasculitis / Q000139:chemically induced* / Q000453:epidemiology
D013205:Staphylococcal Protein A; D011241:Prednisone